Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-level Recall Of One Lot Of Propranolol Hydrochloride Extended-release Capsules, Usp, 60 Mg, Due To Potential Metal Contamination
Recall Summary Breckenridge Pharmaceutical is recalling one lot of Propranolol Hydrochloride Extended-Release Capsules (60 mg) nationwide because the medication may contain metal particles. This blood pressure and heart medication was manufactured by Adare Pharma Solutions and affects consumers who have this specific lot.
- Recalling firm
- Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level
- Product
- One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg,
- Reason
- November 16, 2026— Breckenridge Pharmaceutical, Inc. (Breckenridge) is voluntarily recalling to the consumer level one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions, due to potential metal contamination.
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-11-20
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9884d522-e084-485b-9fac-1617dc458d20